Conduct disorder

Novini vo pedijatrijata / Godi[na revija 2009
9. Orlow SJ. Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical
analysis of current issues. Paediatr Drugs. 2007;9:289–299.
10. Berth-Jones, J, Damstra, RJ, Golsch, S, et al. Twice weekly fluticasone
propionate added to emollient maintenance treatment to reduce risk of relapse
in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003;
326:1367.
11. Lane, JE, Cheyney, JM, Lane, TN, et al. Treatment of recalcitrant atopic
dermatitis with omalizumab. J Am Acad Dermatol 2006; 54:68.
12. Weinberg, JM, Siegfried, EC. Successful treatment of severe atopic dermatitis in
a child and an adult with the T-cell modulator efalizumab. Arch Dermatol 2006;
142:555.
13. Simon, D, Hosli, S, Kostylina, G, et al. Anti-CD20 (rituximab) treatment
improves atopic eczema. J Allergy Clin Immunol 2008; 121:122.
14. Staab D, Diepgen TL, Fartasch M, et al. Age related, structured educational
programmes for the management of atopic dermatitis in children and
adolescents: multicentre, randomised controlled trial. BMJ. 2006;332:933–938.
Страна 203